<DOC>
	<DOCNO>NCT02007772</DOCNO>
	<brief_summary>The purpose trial ist investigate difference efficacy two system breath support patient COPD .</brief_summary>
	<brief_title>Effectiveness TNI vs. BiPAP Chronic Global Insufficiency COPD Patients</brief_title>
	<detailed_description>The trial consist 12 week therapy divide two section . In first 6-week section patient receive treatment either TNI BiPAP second 6-week section treatment change . The start therapy allocate patient via randomisation start directly baseline visit . The treatment follow-up period end second visit second treatment section patient decide device he/she want use .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>presence COPD chronic respiratory global insufficiency chronic dayhypercapnia pCO2 &gt; = 50 mmHg typical symptom ventilatory insufficiency OR patient exacerbation ( abate acute symptomatology ) document hypercapnia &gt; = 50 mmHG preliminary finding age 18 old patient caretaker must able operate device specific train patient must willing use nHF/BiPAPdevice whole trial period least 5 hours/day patient must able answer questionnaire write informed consent obtain presence acute respiratory insufficiency exacerbation type I II last 4 week conservative therapy include longterm oxygen therapy accord GOLD update 2011 exhaust previous treatment NIV ( noninvasive ventilation ) last 14 day clinical instability acute illness ( e.g . acute myocardial infarction , tachycardial atrial fibrillation ) sign cardial decompensation ( e.g . edema low limb , pleural effusion ) serious concomitant disease , assessment eligibility discretion investigator contraindication NIV anamnestic suspicion proven obstructive sleep apnea ( OSA ) relevant systemic infection , assessment eligibility discretion investigator BMI &gt; 30 additional pulmonary disease genesis disease affect breathing ( e.g . mucoviscidosis , scoliosis , muscular disease ) lack compliance participation interventional trial time pregnant nursing woman fertile female patient without effective contraceptive measure trial participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>COPD , nHF , BiPAP</keyword>
</DOC>